How the Microbiome Communicates With the Brain, Immune System & Metabolism

The human microbiome does far more than help digest food. It behaves like a communication network, constantly exchanging signals with the nervous, immune, and metabolic systems. This two-way signaling is one reason changes in the gut microbiome are linked with mood, stress, sleep, appetite, inflammation, and metabolic health.

This article looks at how microbes communicate with the body, through nerves, immune messengers, and the molecules they produce, and is careful to separate what is well established from what is still emerging. Many of the detailed mechanisms come from animal and laboratory work, and the human evidence, while growing, is more modest, so the aim here is an accurate map rather than an overpromise.

Quick Answer: How does the microbiome communicate with the body?

Gut microbes signal to the rest of the body through several channels at once: the vagus nerve and the gut's own nervous system, immune messengers such as cytokines, hormones, and the metabolites microbes make, especially short-chain fatty acids from fiber. Through these channels the microbiome is linked with brain function, immune regulation, and metabolism. The strongest evidence is for the underlying pathways and for effects on the immune system and metabolism; the direct effects on the brain are shown mostly in animals so far, with smaller human effects on mood. It is best understood as an influential signaling system, not a switch that controls health on its own.

For background, see our human microbiome science guide, our overview of how the gut microbiome forms and changes, and the human microbiome hub for the full series.

The Main Channels of Microbiome Communication

Rather than a single line to the brain, the microbiome uses several overlapping routes:

• Neural signaling, through the vagus nerve and the gut's own enteric nervous system.

• Immune messengers, such as cytokines, that pass information between microbes and immune cells.

• Microbial metabolites, especially short-chain fatty acids made when microbes ferment dietary fiber.

• Endocrine signals, including gut hormones involved in appetite and metabolism.

The sections below walk through how these channels connect the microbiome to the brain, the immune system, and metabolism.

Gut-Brain Signaling

The gut and brain communicate continuously in both directions, a network often called the gut-brain axis. Gut microbes can influence this conversation through the vagus nerve, immune signaling, hormones, and metabolites. A widely cited review in Nature Reviews Neuroscience described how gut microbes can affect brain function and behavior through these neural, immune, and endocrine routes.

This is why an imbalanced gut microbiome is frequently associated with anxiety, low mood, stress sensitivity, and disrupted sleep. It is worth being precise: these are associations reported in studies, and much of the detailed cause-and-effect work is from animal models. The gut is one influence on mood among many, not a proven cause of brain-related symptoms.

Microbial Metabolites: Short-Chain Fatty Acids as Messengers

One of the clearest ways microbes signal is by making metabolites. When gut microbes ferment dietary fiber, they produce short-chain fatty acids, mainly acetate, propionate, and butyrate.

What is well established

Short-chain fatty acids act as biochemical messengers within the gut and body. They provide energy to the cells lining the colon, help regulate immune cell function, support the gut barrier, and influence insulin sensitivity and energy balance. These roles are well supported in human and animal research and are summarized in a key review in Cell.

What is still emerging

The idea that these same metabolites shape the brain is promising but earlier-stage. In mice, short-chain fatty acids help the brain's own immune cells, the microglia, mature and function normally. Whether, and how much, this translates into meaningful effects on human mood and cognition is still being worked out, so it is best treated as an active research direction rather than a settled mechanism. For more on these molecules, see our guide to short-chain fatty acids.

Immune Signaling

The gut is the body's largest immune interface, and a large share of the body's immune cells sit in the tissues that line the intestine. That puts the microbiome in close, constant contact with the immune system.

Communication between microbes and immune cells helps set the balance between tolerance and inflammation, supports appropriate immune activation, and contributes to resolving inflammation once it has done its job. A major review in Cell describes how the microbiota helps induce, train, and regulate the immune system, so that immune cells learn to respond to real threats rather than overreacting. Separately, the intestinal barrier itself is a key part of this system: a healthy epithelial lining, reviewed in Nature Reviews Immunology, keeps the dialogue between microbes and immune cells orderly. You can read more in our gut barrier science guide.

The Oral-Gut Connection

Communication does not begin in the gut alone. The mouth hosts its own large microbial community, and swallowed oral microbes meet the stomach and intestinal environment every day. Under certain conditions, some oral microbes can reach and colonize the gut, where they may contribute to inflammation, a link explored in reviews of the oral microbiome in health and disease. The oral community is best seen as one upstream influence on gut and systemic signaling, not the main driver. For a deeper look, see our guide on how the oral microbiome influences gut health.

Metabolic Signaling

Microbial signaling also reaches metabolism. Through their metabolites, gut microbes are involved in insulin sensitivity, appetite and satiety, and how much energy the body extracts from food, and they interact with gut hormones such as GLP-1. Some of this signaling follows a daily rhythm: work in Cell showed that microbial and host signals oscillate across the circadian cycle in a way that supports metabolic balance.

It is important to keep scale in mind. This is general metabolic support, not a drug-level effect. A probiotic is not a GLP-1 medication and does not replace one. For the fuller picture, see our guide to GLP-1 and the microbiome.

What Is Shown in People and What Is Still Preclinical

Because this is a fast-moving field, it helps to be clear about where the evidence stands.

Stronger in humans: that the microbiome interacts closely with the immune system and metabolism, that short-chain fatty acids support the gut barrier and metabolic health, and that probiotics have a small effect on mood in clinical trials.

Mostly preclinical: the detailed brain mechanisms, such as how microbial metabolites shape brain immune cells and neuro-signaling, which are largely demonstrated in animals. These are reasons for interest and further study, not proof of clinical effects in people.

What Supports Healthy Microbiome Communication

Everyday habits support this signaling system more than any single product. The main levers are a varied intake of dietary fibers that feed short-chain fatty acid production, a well-supported gut barrier, a regular daily and sleep rhythm, stress management, and reasonable oral hygiene. Akkermansia muciniphila is one of several mucus-associated microbes studied in relation to the gut barrier and metabolic signaling, and it is one part of this larger picture rather than a stand-alone answer.

Why This Matters

Seeing the microbiome as a communication system helps explain why gut health connects to digestion, immune balance, stress resilience, sleep, and metabolism at the same time, rather than as separate, unrelated issues. It also sets realistic expectations: supporting this signaling with diet and lifestyle is sensible and low-risk, while specific symptoms still deserve proper evaluation. If you have persistent digestive, mood, sleep, or metabolic symptoms, a healthcare professional can help you sort out the cause.

A Note on Supplements

Most of what supports microbiome communication is diet and lifestyle, not a supplement. If you are an adult who wants to add one to a healthy routine, you can learn more about our Akkermansia Chewable. Treat it as general microbiome support rather than a treatment, and products containing Akkermansia are intended for adults and adolescents aged 12 and over. Check with a clinician if you are pregnant, nursing, immunocompromised, managing a health condition, or taking medication.

Frequently Asked Questions About Microbiome Communication

1. What is the gut-brain axis?

It is the continuous, two-way communication network between the gut, including its microbes, and the brain, carried by nerves, immune signals, hormones, and microbial metabolites.

2. How does the microbiome communicate with the body?

Through several channels at once: the vagus nerve and the gut's nervous system, immune messengers such as cytokines, hormones, and metabolites like short-chain fatty acids. These reach the brain, immune tissues, and metabolic organs.

3. Can gut microbes influence mood and stress?

They may. Microbial metabolites and immune signals can interact with pathways involved in mood and the stress response, and probiotics show a small effect on depressive symptoms in clinical trials. Much of the detailed mechanism is still from animal studies, so this is an area of active research rather than a settled or guaranteed effect. Persistent mood or stress problems are worth discussing with a professional.

4. Is microbiome communication only about the brain?

No. Microbes also communicate with immune cells, metabolic tissues, and endocrine organs, which is why gut health connects to immunity, metabolism, and more, not only mood.

5. Does the oral microbiome matter here?

Yes, as an upstream influence. Oral microbes are swallowed daily, and under certain conditions some can reach the gut and affect gut and systemic signaling. It is one contributing factor rather than the main one.

6. Are these effects proven in people?

Partly. The communication pathways, the immune and metabolic roles, and a small mood effect from probiotics have human support. The detailed brain mechanisms are shown mostly in animals so far. It is fair to call this a promising, fast-developing field rather than settled clinical science.

Scientific References

1. Cryan JF, Dinan TG.
   Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
   Nature Reviews Neuroscience 2012;13(10):701-712 
   doi:10.1038/nrn3346 (Review)

2. Cryan JF, O'Riordan KJ, Cowan CSM, et al. 
   The Microbiota-Gut-Brain Axis
   Physiological Reviews 2019;99(4):1877-2013 
   doi:10.1152/physrev.00018.2018 (Comprehensive review)

3. Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F.
   From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites
   Cell 2016;165(6):1332-1345
   doi:10.1016/j.cell.2016.05.041 (Review)

4. Erny D, Hrabe de Angelis AL, Jaitin D, et al.
   Host microbiota constantly control maturation and function of microglia in the CNS 
   Nature Neuroscience 2015;18(7):965-977
   doi:10.1038/nn.4030 (Animal, mouse; short-chain fatty acids and brain immune cells)

5. Belkaid Y, Hand TW.
   Role of the microbiota in immunity and inflammation
   Cell 2014;157(1):121-141
   doi:10.1016/j.cell.2014.03.011 (Review; microbial education of the immune system)

6. Turner JR.
   Intestinal mucosal barrier function in health and disease
   Nature Reviews Immunology 2009;9(11):799-809
   doi:10.1038/nri2653 (Review; intestinal barrier)

7. Willis JR, Gabaldon T.
   The human oral microbiome in health and disease 2020
   (Review of the oral microbiome)

8. Thaiss CA, Zeevi D, Levy M, et al.
   Transkingdom control of microbiota diurnal oscillations promotes metabolic homeostasis
   Cell 2014;159(3):514-529
   doi:10.1016/j.cell.2014.09.048 (Animal and human; circadian microbiome and metabolism. Corrects the earlier "Science, 2016" attribution)

9. Effects of prebiotics and probiotics on symptoms of depression and anxiety in clinically diagnosed samples: systematic review and meta-analysis of randomized controlled trials 2025
   (Human systematic review; small effect of probiotics on depressive symptoms)

10. Cani PD, Depommier C, Derrien M, Everard A, de Vos WM.
    Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms 
    Nature Reviews Gastroenterology and Hepatology 2022;19(10):625-637
    doi:10.1038/s41575-022-00631-9 (Review)

Written by Ali Rıza Akın

Microbiome Scientist, Author & Founder of Next-Microbiome

Ali Rıza Akın is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation.

His work focuses on how microbial ecosystems interact with human physiology, including:

• Gut barrier function and intestinal permeability

• Mucus-associated microbiota (Akkermansia-related systems)

• Oral–gut microbiome axis

• Short-chain fatty acids (SCFAs) and metabolic signaling

• Circadian rhythm–microbiome interactions

• Clinical Research Contributions

He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including:

Active Ulcerative Colitis (Inflammatory Bowel Disease)

Hyperoxaluria (Oxalate Metabolism Disorder)

Microbiome-driven gut health and inflammatory conditions

These studies were part of broader clinical development programs evaluating microbiome-based approaches. His contributions focused on the early-stage scientific and translational pipeline, including strain discovery, functional optimization, and multi-strain formulation design.

Scientific Contributions:

Ali Rıza Akın is the discoverer of Christensenella californii, a bacterial species associated with microbiome diversity and metabolic health.

He is a contributing author to scientific publications and Bacterial Therapy of Cancer (Springer), and the author of Bakterin Kadar Yaşa: İçimizdeki Evren: Mikrobiyotamız.

Approach:

His work emphasizes evidence-based microbiome science, long-term safety, and a systems-based understanding of how microbes influence human health.

Review and Sources

This article is written and reviewed by a microbiome scientist and draws on the peer-reviewed studies listed in the References. It separates human evidence from animal and laboratory findings, labels the strength of the evidence where it matters, and presents microbiome signaling as an influential but still-developing area rather than settled clinical fact. It is reviewed periodically against current research.

Medical Disclaimer

This content is for educational and informational purposes only and is not medical advice, diagnosis, or treatment. It does not diagnose or treat any condition. Probiotics and dietary supplements are not a substitute for medical care or for prescribed medication, including GLP-1 receptor agonist medications such as those sold under the names Ozempic, Wegovy, Mounjaro, and Zepbound, and no supplement should be used to replace or delay prescribed treatment. Dietary supplements are not reviewed or approved by the US Food and Drug Administration for effectiveness before they are sold, and products containing Akkermansia muciniphila are intended for adults and adolescents aged 12 and over under existing international regulatory clearances. If you are pregnant or nursing, are immunocompromised, take medication, are managing a health condition, or have persistent mood, sleep, digestive, or metabolic symptoms, consult a qualified healthcare professional before starting a probiotic or changing your routine.

Last reviewed: August 2026